Ebvallo approval ushers in off-the-shelf T-cell immunotherapies
Patient-derived CAR-T immunotherapies have dominated the cancer immunotherapy space over the last decade. The EU…
December 20, 2022 - 6 minutes
Patient-derived CAR-T immunotherapies have dominated the cancer immunotherapy space over the last decade. The EU…